Healthcare -
Biotechnology - NASDAQ - US
$ 72.92
-2.75 %
$ 5.22 B
Market Cap
-18.55
P/E
Price Target
Average
53.59%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
31.50%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Nuvalent, Inc.
Wall Street analysts predict an average 1-year price target for NUVL of $112 , with forecasts ranging from
a
low of
$97 to a high of $135 .
NUVL Lowest Price Target
Wall Street Target
97 USD
33.02%
NUVL Average Price Target
Wall Street Target
112 USD
53.59%
NUVL Highest Price Target
Wall Street Target
135 USD
85.13%
REVENUE FORECAST
Revenue Forecast Chart NUVL
EBIT FORECAST
EBIT Forecast Chart NUVL
NET INCOME FORECAST
Net Income Chart NUVL